SE0202692D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE0202692D0
SE0202692D0 SE0202692A SE0202692A SE0202692D0 SE 0202692 D0 SE0202692 D0 SE 0202692D0 SE 0202692 A SE0202692 A SE 0202692A SE 0202692 A SE0202692 A SE 0202692A SE 0202692 D0 SE0202692 D0 SE 0202692D0
Authority
SE
Sweden
Prior art keywords
compounds
pharmaceutical compositions
therapy
preparing
processes
Prior art date
Application number
SE0202692A
Other languages
Swedish (sv)
Inventor
Balint Gabos
Michael Lundkvist
Magnus Munck Af Rosenschoeld
Igor Shamovsky
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202692A priority Critical patent/SE0202692D0/en
Publication of SE0202692D0 publication Critical patent/SE0202692D0/en
Priority to PCT/SE2003/001406 priority patent/WO2004024060A2/en
Priority to AU2003258941A priority patent/AU2003258941A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Abstract

The invention provides compounds of formula, in which X, Y, R<1>, G<1> and G<2> have the meanings defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
SE0202692A 2002-09-11 2002-09-11 Compounds SE0202692D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0202692A SE0202692D0 (en) 2002-09-11 2002-09-11 Compounds
PCT/SE2003/001406 WO2004024060A2 (en) 2002-09-11 2003-09-10 Metalloproteinase inhibitors and intermediates for preparation thereof
AU2003258941A AU2003258941A1 (en) 2002-09-11 2003-09-10 Metalloproteinase inhibitors and intermediates for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202692A SE0202692D0 (en) 2002-09-11 2002-09-11 Compounds

Publications (1)

Publication Number Publication Date
SE0202692D0 true SE0202692D0 (en) 2002-09-11

Family

ID=20288962

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202692A SE0202692D0 (en) 2002-09-11 2002-09-11 Compounds

Country Status (3)

Country Link
AU (1) AU2003258941A1 (en)
SE (1) SE0202692D0 (en)
WO (1) WO2004024060A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (en) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (en) 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
SE0202539D0 (en) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006019831A1 (en) 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
JP2008507518A (en) 2004-07-22 2008-03-13 ピーティーシー セラピューティクス，インコーポレーテッド Thienopyridine for treating hepatitis C
US7858666B2 (en) 2007-06-08 2010-12-28 Mannkind Corporation IRE-1α inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2745875A (en) * 1953-06-30 1956-05-15 Hoechst Ag Preparation of nu-acylamino-phenylpropane diols
GB1117617A (en) * 1964-09-23 1968-06-19 Warner Lambert Pharmaceutical Threo-phenylserine ester derivatives
AU3767693A (en) * 1992-03-27 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Pyridylserine derivative
EP1191024A1 (en) * 2000-09-22 2002-03-27 Harald Tschesche Thiadiazines and their use as inhibitors of metalloproteinases
BR0208105A (en) * 2001-03-15 2004-03-09 Astrazeneca Ab Metalloproteinase Inhibitors
SE0100903D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
AU2003258941A8 (en) 2004-04-30
WO2004024060A2 (en) 2004-03-25
AU2003258941A1 (en) 2004-04-30
WO2004024060A3 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
SE0104140D0 (en) Novel Compounds
SE0300480D0 (en) Novel compounds
SE0200920D0 (en) Novel compounds
SE0202539D0 (en) Compounds
SE0103836D0 (en) Novel compounds
SE0302811D0 (en) Novel compounds
ATE316083T1 (en) ADAMANTANDE DERIVATIVES
IS6658A (en) New compounds
HK1048990A1 (en) Novel compounds.
SE0301700D0 (en) Novel compounds
MY128924A (en) Novel compounds
DE602004021472D1 (en) Pyrimiidinverbindungen
TW200613243A (en) Novel compounds
SE0302139D0 (en) Novel compounds
SE0302192D0 (en) Novel compounds
TW200604197A (en) New compounds
SE0401762D0 (en) Novel compounds
TW200740781A (en) Novel compounds
MXPA04001968A (en) Oral antidiabetic agents.
SE0101038D0 (en) Novel compounds
SE0402925D0 (en) Novel Compounds
GB0104050D0 (en) Chemical compounds
GB0120461D0 (en) Novel compounds
SE0401763D0 (en) Compounds
SE0303280D0 (en) Novel compounds